Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 104

Sort by

Sort Order Select

Journal Articles

CD19/CD22 Dual-Targeted Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Aggressive B-Cell Lymphoma: a Safety and Efficacy Study

Yongxian Hu, MD, Yanlei Zhang, Houli Zhao, MD, Yiyun Wang, Arnon Nagler, MD, Alex Hong Chang, He Huang, MD PhD

Blood (2020) 136 (Supplement 1): 34.

https://doi.org/10.1182/blood-2020-143239

Published: 2020

Journal Articles

Salvage Therapy with Low-Dose Ruxolitinib Led to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients with cGvHD after Allogeneic Hematopoietic Stem Cell Transplantation

He Huang, MD PhD, Yanmin Zhao, MD, Guifang Ouyang, Jimin Shi, MD, Yi Luo, MD, Yamin Tan, MD, Jian Yu, MD, Huarui Fu, MD, Xiaoyu Lai, MD, Lizhen Liu, MD

Blood (2020) 136 (Supplement 1): 43–44.

https://doi.org/10.1182/blood-2020-141546

Published: 2020

Journal Articles

The Safety and Efficacy of a CRISPR/Cas9-Engineered Universal CAR-T Cell Product (CTA101) in Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Yongxian Hu, MD, Yali Zhou, Mingming Zhang, MD, Wengang Ge, Yi Li, MD, Li Yang, MD, Guoqing Wei, MD, Lu Han, Hao Wang, Xingwang Zhang, PhD, Jiangtao Ren, PhD, He Huang, MD PhD

Blood (2020) 136 (Supplement 1): 52.

https://doi.org/10.1182/blood-2020-142262

Published: 2020

Journal Articles

Clinical Characterization and Risk Factors Associated with Cytokine Release Syndrome Induced By COVID-19 and Chimeric Antigen Receptor T-Cell Therapy

Ruimin Hong, Houli Zhao, MD, Yiyun Wang, Yu Chen, Hongliu Cai, Yongxian Hu, MD, Guoqing Wei, MD, He Huang, MD PhD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-139007

Published: 2020

Journal Articles

Ruxolitinib for Steroid-Refractory cGvHD: A Significant Response in Heavily Pretreated Patients after Haploidentical-SCT

Hengwei Wu, MD, Jimin Shi, MD, Yi Luo, MD, Yamin Tan, MD, Mingming Zhang, MD, Xiaoyu Lai, MD, Jian Yu, MD, Lizhen Liu, MD, Huarui Fu, MD, He Huang, MD PhD, Yanmin Zhao, MD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-141561

Published: 2020

Journal Articles

CCL2 Promotes Macrophages-Associated Chemoresistance Via MCPIP1 Dual Catalytic Activities in Multiple Myeloma

Ruyi Xu, Yi Li, MD, Haimeng Yan, MD, Xi Huang, MD, He Huang, MD PhD, Zhen Cai, MD PhD

Blood (2019) 134 (Supplement_1): 3086.

https://doi.org/10.1182/blood-2019-126498

Published: 2019

Journal Articles

Eltrombopag Treatment for Patients with Thrombocytopenia Post-Transplantation Showed a Good Chance of Platelet Recovery

Fei Gao, MD, Yanmin Zhao, MD, He Huang, MD PhD

Blood (2019) 134 (Supplement_1): 5658.

https://doi.org/10.1182/blood-2019-125759

Published: 2019

Journal Articles

Calcineurin Inhibitors Replacement By Ruxolitinib As Graft Versus Host Disease Prophylaxis for Patients after Allogeneic Stem Cell Transplantation

Yanmin Zhao, MD, He Huang, MD PhD

Blood (2019) 134 (Supplement_1): 5674.

https://doi.org/10.1182/blood-2019-125803

Published: 2019

Journal Articles

Galectin-9 from Bone Marrow Mesenchymal Stromal Cells Mediates Immunosuppression on Chimeric Antigen Receptor T Cells

Xinyi Teng, BS, Hao Zhang, MD, Zuyu Liang, MD, Mi Shao, MD, Xiujian Wang, MD, Lijuan Ding, MD, Jiazhen Cui, msc, Yongxian Hu, MD, He Huang, MD PhD

Blood (2019) 134 (Supplement_1): 5609.

https://doi.org/10.1182/blood-2019-131680

Published: 2019

Journal Articles

Comparison of Chimeric Antigen Receptor T Cells from Allogenic or Autologous Sources in Patients with Acute Lymphoblastic Leukemia

Yongxian Hu, MD PhD, Jiasheng Wang, MD, Yanlei Zhang, Guoqing Wei, MD, Huijun Xu, Wenjun Wu, MD, Jian Yu, MD, Yi Luo, MD, Jimin Shi, MD, Shaohui Liu, Kangyan Wang, Zhenxing Guo, Alex HONGSHENG Chang, He Huang, MD PhD

Blood (2018) 132 (Supplement 1): 2691.

https://doi.org/10.1182/blood-2018-99-117910

Published: 2018

Journal Articles

Autophagy and Ubiquitin-Mediated Proteolytic Degradation of PML/RarÎ± Fusion Protein in Matrine-Induced Differentiation Sensitivity Recovery of ATRA-Resistant APL (NB4-LR1) Cells: In Vitro and In Vivo studies

Dijiong Wu, Keding Shao, MD, Qihao Zhou, MD, Jie Sun, Ziqi Wang, Fei Yan, Tingting Liu, Xiangping Wu, Baodong Ye, He Huang, MD PhD, Yuhong Zhou

Blood (2018) 132 (Supplement 1): 2646.

https://doi.org/10.1182/blood-2018-99-115699

Published: 2018

Journal Articles

Outcome and Risk Factors of Transplantation-Associated Active Tuberculosis in Allogeneic Haematopoietic Stem Cell Transplantation: A Nested Case Control Study

Yanmin Zhao, MD, Apeng Yang, MD, Jimin Shi, MD, Yi Luo, MD, Xiaoyu Lai, PhD, Yamin Tan, MD, Jian Yu, MD, He Huang, MD PhD

Blood (2018) 132 (Supplement 1): 3427.

https://doi.org/10.1182/blood-2018-99-119027

Published: 2018

Journal Articles

Ruxolitinib Combined with Etanercept for Patients with Corticosteroid-Refractory Acute Graft Versus Host Disease after Allogeneic Stem Cell Transplantation: A Multi-Center Prospective Study

Yanmin Zhao, MD, Jimin Shi, MD, Xiaoqing Li, Yi Luo, MD, Yamin Tan, MD, Xiaoyu Lai, PhD, Jian Yu, MD, Jianping Lan, PhD, Wanmao Ni, PhD, Lieguang Chen, MD, He Huang, MD PhD

Blood (2018) 132 (Supplement 1): 4561.

https://doi.org/10.1182/blood-2018-99-118649

Published: 2018

Journal Articles

Induced IL-17-Producing Γδt Cells Play a Protective Role in Intestinal Graft-Versus-Host Disease

Lin Xu, Jingjing Feng, MD, Yu Lin, PhD, Xiaoqing Li, He Huang, MD PhD

Blood (2018) 132 (Supplement 1): 4568.

https://doi.org/10.1182/blood-2018-99-119161

Published: 2018

Journal Articles

Therapeutic Effect of Platelet Transfusion in Patients with Acute Lymphocytes Treated with CART Therapy

Liu Yan, MD, Xie Jue, MD PhD, Yongxian Hu, MD PhD, He Huang, MD PhD

Blood (2018) 132 (Supplement 1): 5073.

https://doi.org/10.1182/blood-2018-99-120108

Published: 2018

Journal Articles

Profile of Capillary-Leak Syndrome in Patients Received Chimeric Antigen Receptor T Cell Therapy

Yongxian Hu, MD PhD, Jingjing Feng, MD, Mi Shao, He Huang, MD PhD

Blood (2018) 132 (Supplement 1): 5204.

https://doi.org/10.1182/blood-2018-99-117602

Published: 2018

Journal Articles

Haploinsufficiency for NR3C1 Drives Glucocorticoid Resistance By Inactivation the PI3K/AKT/GSK3β/Bim Pathway in Adult Acute Lymphoblastic Leukemia

Xiao Haowen, MD PhD, Yingying Ding, Yang Gao, Limengmeng Wang, PhD, Huafang Wang, Xiaohong Yu, He Huang, MD PhD

Blood (2018) 132 (Supplement 1): 1328.

https://doi.org/10.1182/blood-2018-99-120089

Published: 2018

Journal Articles

Chimeric Antigen Receptor T-Cell Therapy Shapes T Cell Repertoire in Chinese Patients with B-Cell Acute Lymphocyte Leukemia

Blood (2018) 132 (Supplement 1): 1413.

https://doi.org/10.1182/blood-2018-99-115780

Published: 2018

Journal Articles

Changes of T Lymphocyte Subsets after CAR-T Cell Therapy and Its Clinical Significance

Lijuan Ding, Jiazhen Cui, Yongxian Hu, MD PhD, Huijun Xu, Yanlei Zhang, Shaohui Liu, Kangyan Wang, Zhenxing Guo, AlexH Chang, MD, PhD, He Huang, MD PhD

Blood (2018) 132 (Supplement 1): 1423.

https://doi.org/10.1182/blood-2018-99-117885

Published: 2018

Journal Articles

A Pilot Prospective Single-Arm Clinical Study on Decitabine Plus CAG or IA Followed with HLA-Mismatched Nonmyeloablative Transplantation (micro transplantation) on De Novo Elderly Acute Myeloid Leukemia and Int-2/High Risk Myelodysplastic Syndrome Patients

Jie Sun, Yan Huang, Weijia Huang, Lizhen Liu, Jimei Ge, Yunfei Qiu, Zhang En Fan, Xiaorong Hu, Zhen Cai, MD PhD, He Huang, MD PhD

Blood (2018) 132 (Supplement 1): 2188.

https://doi.org/10.1182/blood-2018-99-119136

Published: 2018

NARROW

CD19/CD22 Dual-Targeted Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Aggressive B-Cell Lymphoma: a Safety and Efficacy Study

Salvage Therapy with Low-Dose Ruxolitinib Led to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients with cGvHD after Allogeneic Hematopoietic Stem Cell Transplantation

The Safety and Efficacy of a CRISPR/Cas9-Engineered Universal CAR-T Cell Product (CTA101) in Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Clinical Characterization and Risk Factors Associated with Cytokine Release Syndrome Induced By COVID-19 and Chimeric Antigen Receptor T-Cell Therapy

Ruxolitinib for Steroid-Refractory cGvHD: A Significant Response in Heavily Pretreated Patients after Haploidentical-SCT

CCL2 Promotes Macrophages-Associated Chemoresistance Via MCPIP1 Dual Catalytic Activities in Multiple Myeloma

Eltrombopag Treatment for Patients with Thrombocytopenia Post-Transplantation Showed a Good Chance of Platelet Recovery

Calcineurin Inhibitors Replacement By Ruxolitinib As Graft Versus Host Disease Prophylaxis for Patients after Allogeneic Stem Cell Transplantation

Galectin-9 from Bone Marrow Mesenchymal Stromal Cells Mediates Immunosuppression on Chimeric Antigen Receptor T Cells

Comparison of Chimeric Antigen Receptor T Cells from Allogenic or Autologous Sources in Patients with Acute Lymphoblastic Leukemia

Autophagy and Ubiquitin-Mediated Proteolytic Degradation of PML/RarÎ± Fusion Protein in Matrine-Induced Differentiation Sensitivity Recovery of ATRA-Resistant APL (NB4-LR1) Cells: In Vitro and In Vivo studies

Outcome and Risk Factors of Transplantation-Associated Active Tuberculosis in Allogeneic Haematopoietic Stem Cell Transplantation: A Nested Case Control Study

Ruxolitinib Combined with Etanercept for Patients with Corticosteroid-Refractory Acute Graft Versus Host Disease after Allogeneic Stem Cell Transplantation: A Multi-Center Prospective Study

Induced IL-17-Producing Γδt Cells Play a Protective Role in Intestinal Graft-Versus-Host Disease

Therapeutic Effect of Platelet Transfusion in Patients with Acute Lymphocytes Treated with CART Therapy

Profile of Capillary-Leak Syndrome in Patients Received Chimeric Antigen Receptor T Cell Therapy

Haploinsufficiency for NR3C1 Drives Glucocorticoid Resistance By Inactivation the PI3K/AKT/GSK3β/Bim Pathway in Adult Acute Lymphoblastic Leukemia

Chimeric Antigen Receptor T-Cell Therapy Shapes T Cell Repertoire in Chinese Patients with B-Cell Acute Lymphocyte Leukemia

Changes of T Lymphocyte Subsets after CAR-T Cell Therapy and Its Clinical Significance

A Pilot Prospective Single-Arm Clinical Study on Decitabine Plus CAG or IA Followed with HLA-Mismatched Nonmyeloablative Transplantation (micro transplantation) on De Novo Elderly Acute Myeloid Leukemia and Int-2/High Risk Myelodysplastic Syndrome Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only